Systemic quinolones and risk of retinal detachment I: analysis of data from the US FDA Adverse Event Reporting System

CONCLUSION: Moxifloxacin is the only quinolone showing a positive disproportionality signal for RD. Further epidemiologic research is needed to clarify the association between moxifloxacin and the risk of RD.PMID:34641748 | DOI:10.1080/14740338.2022.1993187

Source: Expert Opinion on Drug Safety - October 13, 2021 Category: Drugs & Pharmacology Authors: Mohamed Kadry Taher Abdallah Alami Christopher A Gravel Derek Tsui Lise M Bjerre Franco Momoli Donald Mattison Daniel Krewski Source Type: research